Eastman Chemical Company
EMNBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Sep 9, 2026
Scan Results
Daily timeframeEastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The $8.05B market capitalization puts EMN squarely in mid-cap range for its industry. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Market Cap
$8.05B
Beta
1.09
P/E (TTM)
18.33
P/E (Fwd)
10.15
EPS (TTM)
$3.84
EPS (Fwd)
$6.93
ROE
7.3%
ROA
3.5%
Cash
$693.0M
Total Debt
$5.47B
Free CF
$544.6M
52W Change
5.3%
Annual Financials
Cash vs Debt
Where EMN stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, EMN finished 0.35% above its 150-day moving average ($71.91) and 3.81% above its 200-day moving average ($69.51). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is EMN overbought or oversold?
At the September 3, 2026 close, EMN's RSI(14) was 44.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, EMN has $693.0M in cash with $5.47B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $544.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 7.3%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.5% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $10.58B (2022) to $8.75B (2025), a 17% decline worth watching.
Eastman Chemical Company carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Eastman Chemical Company and its sector.